Ritodrine

PRE-PAR 10 mg/ml SOLUCION INYECTABLE

10 mg solución inyectableSpainMarketedAuthorised 30 Apr 1973

In other countries

The same active substances on other registers, the same brand first.

Yutopar 50MG-5ML I.V. AmpouleSaudi Arabia · SpimacoSame form
Ritodrine HCLUnited States · 10MG/ML, 15MG/ML · Injectable · Quad PharmsSame form
Ritodrine HydrochlorideUnited States · 10MG/ML, 15MG/ML · injectable · Abraxis PharmSame form
Ritodrine Hydrochloride in Dextrose 5% in Plastic ContainerUnited States · 30MG/100ML · injectable · HospiraSame form
MiodrinaBrazil · Apsen Farmaceutica S/ASame substance
Yutopar Inj 50MG/5MLCanada · 10 MG / ML · Liquid · Bristol Labs Division of Bristol-Myers SquibbSame substance
Yutopar Tab 10MGCanada · 10 MG / TAB · Tablet · Bristol Labs Division of Bristol-Myers Squibb

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ritodrine

PRE-PAR 10 mg/ml SOLUCION INYECTABLE

10 mg solución inyectableSpainMarketedAuthorised 30 Apr 1973

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Yutopar 10MG TabletSaudi Arabia · Saja-Saudi Arabian Japanese Pharmaceutical Co

Packs

Pack	Code	Status
PRE-PAR 10 mg/ml SOLUCION INYECTABLE , 3 ampollas de 5 ml	809319

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ritodrine
Strength: 10 mg
Dosage form: solución inyectable
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 30 Apr 1973
Registration: 51227
Marketing authorisation holder: Laboratorio Reig Jofre, S.A.
Procedure: National, MRP or DCP
Supply: Uso Hospitalario